# A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump

> **NCT07152730** · PHASE1 · WITHDRAWN · sponsor: **Ferring Pharmaceuticals**

## Conditions studied

- Amenorrhea
- Fertility
- Infertility

## Interventions

- **DRUG:** Lutrepulse

## Key facts

- **NCT ID:** NCT07152730
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09-12
- **Primary completion:** 2025-10-29
- **Final completion:** 2025-10-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The decision to terminate development activities was based on business needs and unrelated to any safety or efficacy concerns.
- **Last updated:** 2025-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07152730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07152730, "A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT07152730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*